147 related articles for article (PubMed ID: 21450372)
1. [Collecting duct renal cell carcinoma].
Husillos A; Herranz-Amo F; Subirá D; Lledó E; Molina-Escudero R; Hernández-Fernández C
Actas Urol Esp; 2011 Jun; 35(6):368-71. PubMed ID: 21450372
[TBL] [Abstract][Full Text] [Related]
2. [Carcinoma of the Bellini collecting duct in paediatric patients: a case report and review of the literature].
Gurrera A; Amico P; Di Cataldo A; Vasquez E; Magro G
Pathologica; 2007 Oct; 99(5):301-5. PubMed ID: 18354951
[TBL] [Abstract][Full Text] [Related]
3. [Effective palliative chemotherapy in a patient with collecting duct carcinoma of a unilateral kidney associated with anuria. Case report].
Kullmann T; Pintér T; Szepesvári Z; Kránitz N; Culine S
Orv Hetil; 2016 Mar; 157(11):436-9. PubMed ID: 26947093
[TBL] [Abstract][Full Text] [Related]
4. Carcinoma of the collecting ducts of Bellini of the kidney: adjuvant chemotherapy followed by multikinase inhibition with sunitinib.
Staehler M; Schöppler G; Haseke N; Stadler T; Karl A; Siebels M; Ihrler S; Stief CG
Clin Genitourin Cancer; 2009 Jan; 7(1):58-61. PubMed ID: 19213670
[TBL] [Abstract][Full Text] [Related]
5. Is there a place for radical nephrectomy in the presence of metastatic collecting duct (Bellini) carcinoma?
Méjean A; Rouprêt M; Larousserie F; Hopirtean V; Thiounn N; Dufour B
J Urol; 2003 Apr; 169(4):1287-90. PubMed ID: 12629344
[TBL] [Abstract][Full Text] [Related]
6. Carcinoma of the collecting ducts of Bellini of the kidney: adjuvant chemotherapy followed by multikinase-inhibition with sunitinib.
Staehler M; Haseke N; Schöppler G; Stadler T; Karl A; Siebels M; Ihrler S; Stief CG
Eur J Med Res; 2008 Nov; 13(11):531-5. PubMed ID: 19073390
[TBL] [Abstract][Full Text] [Related]
7. Collecting duct carcinoma of the kidney: a clinicopathological study of 9 cases.
Peyromaure M; Thiounn N; Scotté F; Vieillefond A; Debré B; Oudard S
J Urol; 2003 Oct; 170(4 Pt 1):1138-40. PubMed ID: 14501710
[TBL] [Abstract][Full Text] [Related]
8. [Carcinoma of Bellini's collecting tubules. Apropos of a case].
Vigouroux V; Dugardin F; Bottet P; Comoz F; Auriault ML; Di Palma M; Bensadoun H
Prog Urol; 1998 Apr; 8(2):249-53. PubMed ID: 9615936
[TBL] [Abstract][Full Text] [Related]
9. Sorafenib in combination with gemcitabine plus cisplatin chemotherapy in metastatic renal collecting duct carcinoma: A prospective, multicentre, single-arm, phase 2 study.
Sheng X; Cao D; Yuan J; Zhou F; Wei Q; Xie X; Cui C; Chi Z; Si L; Li S; Mao L; Lian B; Tang B; Yan X; Wang X; Kong Y; Dai J; Bai X; Zhou L; Guo J
Eur J Cancer; 2018 Sep; 100():1-7. PubMed ID: 29933095
[TBL] [Abstract][Full Text] [Related]
10. Collecting duct carcinoma of the kidney. A contribution of 4 new cases.
Soto Delgdo M; Pedrero Márquez G; Arroyo Maestre JM; Beardo Villar P
Arch Esp Urol; 2014 Oct; 67(8):714-7. PubMed ID: 25306992
[TBL] [Abstract][Full Text] [Related]
11. A renal cancer with intermediate characteristics between collecting (Bellini) duct carcinoma and urothelial carcinoma: case report and review of the literature.
Maestroni U; Ferretti S; Dinale F; Froio E; Pilato FP; Ciuffreda M; Mellissari M; Cortellini P
Tumori; 2006; 92(6):545-8. PubMed ID: 17260499
[TBL] [Abstract][Full Text] [Related]
12. Collecting duct carcinoma with long survival treated by partial nephrectomy.
Matsumoto H; Wada T; Aoki A; Hoshii Y; Takahashi M; Aizawa S; Naito K
Int J Urol; 2001 Jul; 8(7):401-3. PubMed ID: 11442664
[TBL] [Abstract][Full Text] [Related]
13. Major response and clinical benefit following third-line treatment for Bellini duct carcinoma.
Fakhrai N; Haitel A; Balassy C; Zielinski CC; Schmidinger M
Wien Klin Wochenschr; 2005 Jan; 117(1-2):63-5. PubMed ID: 15986594
[TBL] [Abstract][Full Text] [Related]
14. Collecting duct (Bellini duct) renal cell carcinoma: a nationwide survey in Japan.
Tokuda N; Naito S; Matsuzaki O; Nagashima Y; Ozono S; Igarashi T;
J Urol; 2006 Jul; 176(1):40-3; discussion 43. PubMed ID: 16753362
[TBL] [Abstract][Full Text] [Related]
15. Triple combination of bevacizumab, gemcitabine and platinum salt in metastatic collecting duct carcinoma.
Pécuchet N; Bigot F; Gachet J; Massard C; Albiges L; Teghom C; Allory Y; Méjean A; Escudier B; Oudard S
Ann Oncol; 2013 Dec; 24(12):2963-7. PubMed ID: 24190963
[TBL] [Abstract][Full Text] [Related]
16. [Carcinoma of Bellini's duct].
Portillo Martín JA; Val Bernal F; Martín García B; Hernández Rodríquez R; Correas Gómez MA; Gutiérrez Baños JL; Monge Miralles JM; Roca Edreira A
Actas Urol Esp; 1993 Oct; 17(9):598-602. PubMed ID: 8165944
[TBL] [Abstract][Full Text] [Related]
17. Urinary collecting system invasion is an independent prognostic factor of organ confined renal cell carcinoma.
Verhoest G; Avakian R; Bensalah K; Thuret R; Ficarra V; Artibani W; Tostain J; Guille F; Cindolo L; De La Taille A; Abbou CC; Salomon L; Rioux-Leclercq N; Patard JJ
J Urol; 2009 Sep; 182(3):854-9. PubMed ID: 19616244
[TBL] [Abstract][Full Text] [Related]
18. [Questions for the specialist physician. Bellini's duct carcinoma].
Aktuelle Urol; 2004 Apr; 35(2):111-2. PubMed ID: 15264141
[No Abstract] [Full Text] [Related]
19. Prognostic relevance of capsular involvement and collecting system invasion in stage I and II renal cell carcinoma.
Klatte T; Chung J; Leppert JT; Lam JS; Pantuck AJ; Figlin RA; Belldegrun AS
BJU Int; 2007 Apr; 99(4):821-4. PubMed ID: 17244281
[TBL] [Abstract][Full Text] [Related]
20. Prospective multicenter phase II study of gemcitabine plus platinum salt for metastatic collecting duct carcinoma: results of a GETUG (Groupe d'Etudes des Tumeurs Uro-Génitales) study.
Oudard S; Banu E; Vieillefond A; Fournier L; Priou F; Medioni J; Banu A; Duclos B; Rolland F; Escudier B; Arakelyan N; Culine S;
J Urol; 2007 May; 177(5):1698-702. PubMed ID: 17437788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
